When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Mamas fibrocísticas

Last reviewed: 20 Aug 2025
Last updated: 17 Nov 2023

Summary

定义

病史和体格检查

关键诊断因素

  • presença de fatores de risco
  • mastalgia
  • nódulos simétricos difusos por toda a extensão das duas mamas
完整详情

其他诊断因素

  • idade entre 30 e 50 anos
  • descarga mamilar
  • massa mamária palpável
完整详情

危险因素

  • menopausa de início tardio
  • primeiro parto em idade avançada
  • nuliparidade
  • obesidade
  • terapia de reposição de estrogênio
完整详情

诊断性检查

首要检查

  • mamografia
  • ultrassonografia das mamas
完整详情

需考虑的检查

  • aspiração do cisto
  • biópsia de mama
完整详情

治疗流程

持续性治疗

mastalgia

descarga mamilar

撰稿人

作者

Sonia Sugg, MD

Professor of Surgery

Division of Surgical Oncology and Endocrine Surgery

University of Iowa Hospitals and Clinics

Iowa City

IA

Divulgaciones

SS declares that she has no competing interests.

Ingrid Lizarraga, MBBS, FACS

Clinical Associate Professor

Division of Surgical Oncology and Endocrine Surgery

University of Iowa Hospitals and Clinics

Iowa City

IA

Disclosures

IL declares that she has no competing interests.

Acknowledgements

Dr Sonia Sugg and Dr Ingrid Lizarraga would like to gratefully acknowledge Dr Sophia Fu, Dr Sarah E. Colwick, Dr Hernan I. Vargas, Dr Carol Scott-Connor, Dr Anjali Thawani, and Dr Jesse Dirksen, the previous contributors to this topic. SEC, HIV, CSC, AT and JD declare that they have no competing interests.

Disclosures

SF, SEC, HIV, CSC, AT, and JD declared that they had no competing interests.

Peer reviewers

Fred Dirbas, MD

Assistant Professor of Surgical Oncology

Stanford University

Stanford

CA

Disclosures

FD declares that he has no competing interests.

Justin Stebbing, MA, MRCP, MRCPath, PhD

Consultant Medical Oncologist/Senior Lecturer

Imperial College Healthcare NHS Trust

Charing Cross Hospital

London

UK

Disclosures

JS declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Marchant DJ. Benign breast disease. Obstet Gynecol Clin North Am. 2002 Mar;29(1):1-20. Abstract

Santen RJ, Mansel R. Benign breast disorders. N Engl J Med. 2005 Jul 21;353(3):275-85. Abstract

Love SM, Gelman RS, Silen W. Sounding board. Fibrocystic "disease" of the breast--a nondisease? N Eng J Med. 1982 Oct 14;307(16):1010-4. Abstract

Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985 Jan 17;312(3):146-51. Abstract

Fisher B, Constantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998 Sep 16;90(18):1371-88.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Mamas fibrocísticas images
  • Differentials

    • Dor na parede torácica
    • Costocondrite
    • Fibroadenoma
    More Differentials
  • Guidelines

    • Screening for breast cancer: recommendation statement
    • ACR appropriateness criteria: palpable breast masses
    More Guidelines
  • Patient information

    Câncer de mama localmente avançado: o que é?

    Câncer de mama: CDIS (câncer de mama em estágio muito inicial) em mulheres

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer